The oncogenic properties and RNA of the Fujinami avian sarcoma virus (FSV) and the protein it encodes were investigated and compared to those of other avian tumor viruses with sarcomagenic properties such as Rous sarcoma virus and the acute leukemia viruses MC29 and erythroblastosis virus. Cloned stocks of FSV caused sarcomas in all chickens inoculated and were found to contain a 4.5-kilobase (kb) and an 8.5-kb RNA species. The 4.5-kb RNA was identified as the genome of defective FSV because it was absent from nondefective FSV-associated helper virus and because the titer of focusforming units increased with the ratio of 4.5-kb to 8.5-kb RNA in virus preparations. This is, then, the smallest known tumor virus RNA with a transforming function. Comparisons with other viral RNAs, based on oligonucleotide mapping and molecular hybridization, indicated that 4.5-kb FSV RNA contains a 5' gag gene-related sequence of 1 kb, an internal specific sequence of about 3 kb that is unrelated to Rous sarcoma virus, MC29, and erythroblastosis virus, and a 3'-terminal sequence of about 0.5 kb related to the conserved C region of avian tumor viruses. The lack of some or all nucleotide sequences of the essential virion genes, gag, pol, and env, and the isolation of FSV-transformed nonproducer cell clones indicated that FSV is replication defective. A 140,000-dalton, gag-related nonstructural protein was found in FSV-transformed producer and nonproducer cells and was translated in vitro from full-length FSV RNA. This protein is expected to have a transforming function both because its intracellular concentration showed a positive correlation with the percentage of transformed cells in a culture and because FSV is unlikely to code for major additional proteins since the genetic complexities of FSV RNA and the FSV protein are almost the same. It is concluded that the transforming onc gene of FSV is distinct from that of Rous sarcoma virus and other avian tumor viruses with sarcomagenic properties. Hence, multiple mechanisms exist for sarcomagenic transformation of avian cells.
There are a number of sarcomagenic viruses in the avian tumor virus group that fall into discrete RNA subgroups, defined here on the basis of helper-virus unrelated, specific RNA sequences.
[See below and ref. 1 . Both defective and nondefective viruses can be classified consistently by using RNA subgroups (1) . In contrast, only nondefective viruses can be classified on the basis of envelope subgroups (2) . ] The Rous subgroup includes the replication-defective Bryan Rous sarcoma virus (RSV), the nondefective Schmidt-Ruppin strain, and the Prague strain of RSV (2, 3) . The most common neoplasm produced by the RSV RNA subgroup of viruses is a sarcoma. The Rous subgroup is defined by a related class of transforming genes of 1.5 kilobases (kb) termed src (1, (4) (5) (6) (7) , which are located near the 3' end of viral RNA (6) and encode a 60-kilodalton nonstructural protein product thought to have a transforming function (8, 9) . The ES4 strain of avian erythroblastosis virus (AEV) (ES for erythroblastosis and sarcoma) and the avian myelocytomatosis virus MC29, in addition to acute leukemias and carcinomas, also cause sarcomas in animals and transform fibroblasts in culture (1, 3, 10, 11) . Their RNAs contain specific nucleic acid sequences that, in part, encode nonstructural protein products of about 75-110 kilodaltons with probable transforming function (1, (12) (13) (14) (15) (16) (17) (18) (19) (20) . Thus, AEV and MC29 define two additional subgroups of avian tumor viruses with sarcomagenic properties (1, 20) .
Here we analyze the Fujinami sarcoma virus (FSV) (3, 21) to determine how this virus is related to the known avian tumor viruses with sarcomagenic properties. Sarcoma formation and transformation of cells in culture are the only oncogenic activities that have been reported for this virus (3, (21) (22) (23) (24) (25) . We have found that FSV has a unique transforming onc gene that is unrelated to the src gene of RSV and distinct from those of AEV and MC29. RESULTS Oncogenic Properties of FSV. Fig. 1 A-C shows the morphology of chicken embryo cells [4] [5] days after infection with uncloned FSV (a gift of H. M. Temin) , producing 102 focusforming units (FFU)/ml of FSV, after infection with FSV that was cloned (17) once, producing 103-i04 FFU/ml, and after infection with FSV cloned a second time, producing 104-105 FFU/ml. Passage of FSV-transformed cells (such as those shown in Fig. 1C ) at weekly intervals for [4] [5] [6] weeks reproducibly resulted in cultures that had almost the morphology of normal fibroblasts (see Fig. 1A ) and that released virus at a titer of <102 FFU/ml. Mass cultures and foci of most virus-transformed fibroblasts had a fusiform morphology (Fig. 1) . The growth media of transformed cells became viscous at daily or half-daily intervals, presumably due to hyaluronic acid, whose synthesis and secretion are induced by FSV (24, 25) . FSV-infected fibroblasts also grew into virus-producing and -nonproducing colonies in agar suspension prepared as described (refs. 13 ;lj~i MC29-associated virus RNA standards (12, (27) (28) (29) . The size of the 4.5-kb species is similar to that of the 5-to 6-kb RNAs of defective avian acute leukemia viruses (12, (14) (15) (16) (17) and of defective murine sarcoma viruses (27) (28) (29) , whereas the 8.5-kb RNA is typical of nondefective avian leukemia viruses (26, 30 (31) .
As shown in Fig. 1 (13, 16) . Immunoprecipitation was with normal rabbit serum (left lanes) or antiserum against whole virus (PR RSV-C) (right lanes) (13, 16) . Numbers indicate the size in kilodaltons of known viral proteins: Prl80 gag-pol, Pr76 gag, p27, and the 140-kilodalton FSV protein.
chickens inoculated with FSV-associated helper virus (FAV) (see below).
The RNA of FSV. The RNA monomers of the 50-70S FSV RNA complex were analyzed by polyacrylamide gel electrophoresis (26) . Two species were resolved ( are highly conserved sequences probably belonging to the gag genes of other nondefective avian tumor viruses (6, 32) as well as of the defective acute leukemia viruses, MC29 and AEV, which carry gag-related sequences (Figs. 4 and 5) (12, 14, 16, 17) . However, FSV lacks other conserved gag oligonucleotides (32) . FSV RNA also lacked oligonucleotides that have been diagnosed as conserved markers of the pol and env genes in nondefective avian tumor viruses, signaling the absence of these genes in FSV. FSV contained none of the conserved oligonucleotides of src and none of the specific sequences of MC29 or AEV subgroups of avian acute leukemia viruses (14, 16, 17, 19, 20) . (17) ; t Shared with CMIIAV, the helper virus of CMII virus of the MC29 subgroup (16, 20) .
It is conceivable that FSV-specific oligonucleotides, identified by subtracting those shared with FAV and other avian tumor viruses, represent FSV RNA sequences related to but not identical with FAV, PR-B, MC29, or AEV. To test for this possibility, we searched for specific oligonucleotides from FSV RNA sequences that are subject to competition by RNAs from other viruses of the avian tumor virus group during hybridization with FSV cDNA. For this purpose, FSV(FAV) [32P]RNA was hybridized with cDNA from FSV and FAV that had been prehybridized with a large excess of unlabeled FAV RNA, Under these conditions, only FSV-specific sequences, unrelated to FAV RNA, can form hybrids. The RNA of such hybrids was found to contain all FSV-specific oligonucleotides defined above by subtraction, except for no. 3 and 14 ( Fig. SC; see  below) . The specific FSV oligonucleotides were also not subject to competition by the RNAs of RSV, MC29, and AEV (Fig. 3D) No. 14, resolved as a unique oligonucleotide only in short poly(A)-tagged RNA fragments (not shown), is a variant of the C-oligonucleotide conserved in many other avian tumor viruses (6, 32) , including FAV (Fig. 5) . The specific FSV oligonucleotides (circled in Fig. 4 ) form a contiguous 3-kb RNA section and so represent helper-unrelated, specific genetic information.
A gag Gene-Related, 140-Kilodalton Nonstructural Protein Is Coded by FSV. As shown in Figs. 1 G-I and 6 , a specific protein estimated at 140 kilodaltons from its electrophoretic mobility relative to those of known viral and other (not shown) marker proteins was immunoprecipitated from lysates of FSV-transformed cells by serum against disrupted Prague RSV. Other proteins shown in Figs. 1 and 6 (which are processing intermediates of Pr76 or incomplete translation products) are not FSV specific because they were not found in FSV-transformed nonproducer cells (Fig. 6D) . The intracellular ratio of the 140-kilodalton protein to the helper viral gag gene product, Pr76, increased in parallel both with the ratio of the 4. (Fig. 1) . The 140-kilodalton protein, but not the helper viral proteins, was also found in FSV-transformed nonproducer cells (Fig. 6D) and was absent from FAV-infected cells (not shown). This indicates that the 140-kilodalton protein is coded for by FSV RNA and is involved in transformation. Immunoprecipitation with specific antisera against the gag proteins p27 and p19 demonstrated that the 140-kilodalton FSV protein is related to one or both of these gag gene products (Fig. 6B) . However, the 140-kilodalton protein was not found to be a major component in extracellular virus (not shown). Antiserum against glycoprotein, which precipitated the FAV glycoprotein precursor Pr95, and antiserum against DNA polymerase, which precipitated the polymerase precursor Prl80, both failed to precipitate the 140-kilodalton FSV protein (Fig. 6B) . In vitro translation of virion RNA further proved that FSV RNA, but not FAV RNA, is the template for a 140-kilodalton protein (Fig. 6A) which is indistinguishable from the 140-kilodalton protein synthesized in vivo both on the basis of its electrophoretic (Fig. 6C) and immunological (not shown) properties. Translation of discrete size classes of poly(A)-selected FSV(FAV) RNA demonstrated that full-length 4.5-kb (26S) FSV RNA was the template of the 140-kilodalton protein and that full-length 8.5-kb FAV RNA was the template for the Pr76 protein (Fig. 6A) . Cell-free translation did not reveal any other FSV-specific proteins. We conclude that the 140-kilodalton FSV protein is a gag-related, nonstructural protein that is serologically unrelated to the env and pol gene products of avian tumor viruses. virus RNA with oncogenic function described to date. The a b relatively small size of FSV RNA, the lack of some or all sequences of the three essential virion genes (gag, pol, and env), and the ability of the virus to transform cells in the absence of virus production indicate that FSV is replication defective. The Draw genetic structure of FSV RNA resembles that of defective avian acute leukemia viruses (1, 12, 14, 16, 17, 20) and also those of I_.-no defective mammalian sarcoma viruses (1, 33) . Like these viruses, FSV RNA has an internal, specific RNA sequence flanked by terminal group-specific sequences, the 5'-terminal sequence being gag-related and the 3'-terminal sequence related to the conserved c region of avian tumor viruses (5) . Furthermore, the 140-kilodalton gag gene-related, nonstructural FSV protein resembles gag-related, nonstructural proteins that are diagnostic anslation from of other defective transforming avian (13, 14, (16) (17) (18) (19) (20) and 'o protein (B), mammalian (34, 35) that neither the primary nor the genetic structure of FSV RNA V) RNA fracbears resemblance to the src gene of RSV (5, 6, 32) nor that the ns 4-14) (14) .
140-kilodalton FSV protein resembles the 60-kilodalton src gene om a parallel product (8, 9 (22) . From specific RNA sequences that are unrelated to essential gag, pol, and eny virion genes as a basis for subclassification (1) , FSV is defined as prototype of a distinct subgroup of oncogenic avian tumor viruses. This subgroup also differs from the RSV subgroup of avian sarcoma viruses and the MC29 and AEV subgroups of acute leukemia viruses in specific, nonstructural proteins. Nevertheless, the oncogenic spectrum of FSV strongly overlaps with that of the RSV RNA subgroup (3, [21] [22] [23] [24] [25] and, to a lesser degree, with that of the MC29 and AEV RNA subgroups (10, 11) . Further biological testing of FSV is necessary to fathom the extent of overlap among the oncogenic properties of these viruses. The presence of multiple sarcomagenic RNA subgroups in the avian tumor virus group is mirrored by the murine Moloney and the Harvey-Kirsten sarcoma virus RNA subgroups (1) and the two RNA subgroups of feline sarcoma viruses (38) . Because all known defective sarcomagenic RNA viruses have a genetic structure similar to that of FSV (1, 20, 33) but unlike that of RSV (1, (4) (5) (6) , it would appear that RSV, rather than FSV, is an exceptional sarcoma virus.
The one Gene of FSV. The transforming onc genes of defective transforming tumor viruses have not been defined genetically because onc deletion mutants are biologically undetectable and because recombinants are difficult to define for lack of secondary markers (1, 19, 20) . Moreover, known gene products of defective transforming viruses typically represent only a fraction of the coding capacity of their RNAs (1, 14, 16-20, 33-35, 39) . Although such products have been proposed as having transforming functions (1, 14, 16, 20, 35, 39) , the failure towaccount for all genetic information of a defective virus in terms of protein products leaves open the question as to whether additional, unidentified gene products are also necessary for transformation by these viruses. Because in FSV the genetic complexities of the 4.5-kb FSV RNA and the 140-kilodalton FSV protein approximately coincide, and because the 140-kilodalton FSV protein is a nonstructural protein and also present in nonproducer cells, it appears likely that the onc gene of FSV is identical with the viral RNA and that the 140-kilodalton protein is its only product and, therefore, a transforming protein. A more accurate analysis of the complexity of the viral RNA and protein, as well as genetic data, would be necessary to validate this proposal.
The analysis of FSV and previous analyses of the onc genes of the RSV, MG29, and AEV RNA subgroups of avian tumor viruses indicate that at least four different classes of onc genes that have sarcomagenic potential exist in the avian tumor virus group. Unless the products of each of these onc genes are functionally similar it would follow that multiple mechanisms for sarcomagenic transformation exist in avian cells.
Note Added in Proof. The 140 kilodalton FSV protein is a phosphoprotein in vivo and is also phosphorylated in vitro by itself or by an associated kinase. By contrast, the src gene product of RSV primarily phosphorylates src antibody (9) , and the nonstructural, gag-related protein of AEV does not phosphorylate itself or its antibody (unpublished data 
